Log in to save to my catalogue

Covid-19–Associated Myopathy Caused by Type I Interferonopathy

Covid-19–Associated Myopathy Caused by Type I Interferonopathy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7722689

Covid-19–Associated Myopathy Caused by Type I Interferonopathy

About this item

Full title

Covid-19–Associated Myopathy Caused by Type I Interferonopathy

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2020-12, Vol.383 (24), p.2389-2390

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Generalized, predominantly proximal weakness and a greatly elevated creatine kinase level developed in a man with Covid-19. Immunohistochemical analysis of a muscle-biopsy specimen revealed abnormal expression of MHC-1 and myxovirus resistance protein A on muscle fibers, suggesting type I interferonopathy.

Alternative Titles

Full title

Covid-19–Associated Myopathy Caused by Type I Interferonopathy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7722689

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7722689

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMc2031085

How to access this item